Ⅳ期乳腺癌寡转移局部治疗的研究进展

摘要/Abstract

中图分类号:

R737.9

欧丹, 许赪, 陈佳艺. Ⅳ期乳腺癌寡转移局部治疗的研究进展[J]. 外科理论与实践, 2018, 23(05): 469-472.

[1] Chen W, Zheng R, Baade PD, et al.Cancer statistics in China, 2015[J]. CA Cancer J Clin,2016,66(2):115-132.
[2] Iqbal J, Ginsburg O, Rochon PA, et al.Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States[J]. JAMA,2015,313(2):165-173.
[3] Fisher B, Gunduz N, Coyle J, et al.Presence of a growth-stimulating factor in serum following primary tumor removal in mice[J]. Cancer Res,1989,49(8):1996-2001.
[4] Hellman S, Weichselbaum RR.Oligometastases[J]. J Clin Oncol,1995,13(1):8-10.
[5] Weichselbaum RR, Hellman S.Oligometastases revisited[J]. Nat Rev Clin Oncol,2011,8(6):378-382.
[6] Milano MT, Katz AW, Schell MC, et al.Descriptive analy-sis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy[J]. Int J Radiat Oncol Biol Phys,2008,72(5):1516-1522.
[7] Khan SA, Stewart AK, Morrow M.Does aggressive local therapy improve survival in metastatic breast cancer?[J]. Surgery,2002,132(4):620-627.
[8] Babiera GV, Rao R, Feng L, et al.Effect of primary tumor extirpation in breast cancer patients who present with stageⅣ disease and an intact primary tumor[J]. Ann Surg Oncol,2006,13(6):776-782.
[9] Gnerlich J, Jeffe DB, Deshpande AD, et al.Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data[J]. Ann Surg Oncol,2007,14(8):2187-2194.
[10] Cady B, Nathan NR, Michaelson JS, et al.Matched pair analyses of stage IV breast cancer with or without resection of primary breast site[J]. Ann Surg Oncol,2008,15(12):3384-3395.
[11] Ruiterkamp J, Ernst MF, van de Poll-Franse LV, et al. Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis[J]. Eur J Surg Oncol,2009, 35(11):1146-1151.
[12] Thomas A, Khan SA, Chrischilles EA, et al.Initial surgery and survival in stage Ⅳ breast cancer in the United States, 1988-2011[J]. JAMA Surg,2016,151(5):424-431.
[13] Choi SH, Kim JW, Choi J, et al.Locoregional treatment of the primary tumor in patients with de novo Stage Ⅳ breast cancer: a radiation oncologist's perspective[J]. Clin Breast Cancer,2017,18(2):e167-e178.
[14] Harris E, Barry M, Kell MR.Meta-analysis to determine if surgical resection of the primary tumour in the setting of stage IV breast cancer impacts on survival[J]. Ann Surg Oncol,2013,20(9):2828-2834.
[15] Badwe R, Hawaldar R, Nair N, et al.Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial[J]. Lancet Oncol,2015,16(13):1380-1388.
[16] Fitzal F, Bjelicradisic V, Knauer M, et al. Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase Ⅲ ABCSG-28 POSYTIVE trial[J]. Ann Surg,2018-04-24[Epub ahead of print].
[17] Soran A, Ozmen V, Ozbas S, et al.Randomized trial comparing resection of primary tumor with no surgery in stage Ⅳ breast cancer at presentation: protocol MF07-01[J]. Ann Surg Onco,2018,13(Suppl 1):1-9.
[18] Lu S, Wu J, Fang Y, et al.The impact of surgical excision of the primary tumor in stage IV breast cancer on survival: a meta-analysis[J]. Oncotarget,2018,9(14):11816-11823.
[19] Shien T, Nakamura K, Shibata T, et al.A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017[J]. Jpn J Clin Oncol,2012,42(10):970-973.
[20] Le Scodan R, Stevens D, Brain E, et al.Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy[J]. J Clin Oncol,2009,27(9):1375-1381.
[21] Mauro GP, de Andrade Carvalho H, Stuart SR, et al. Effects of locoregional radiotherapy in patients with metastatic breast cancer[J]. Breast,2016,28:73-78.
[22] Cardoso F, Senkus E, Costa A, et al.4th ESO-ESMO International Consensus Guidelines for advanced breast cancer (ABC 4)[J]. Ann Oncol,2018,29(8):1634-1657.
[23] Steinauer K, Gross MW, Huang DJ, et al.Radiotherapy in patients with distant metastatic breast cancer[J]. Ra-diat Oncol,2014,9:126.
[24] Meimarakis G, Rüttinger D, Stemmler J, et al.Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer[J]. Ann Thorac Surg,2013,95(4):1170-1180.
[25] Chua TC, Saxena A, Liauw W, et al.Hepatic resection for metastatic breast cancer: a systematic review[J]. Eur J Cancer,2011,47(15):2282-2290.
[26] Nanji S, Cleary S, Ryan P, et al.Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival[J]. Ann Surg Oncol,2013,20(1):295-304.
[27] Tasleem S, Bolger JC, Kelly ME, et al. The role of liver resection in patients with metastatic breast cancer: a systematic review examining the survival impact[J]. Ir J Med Sci,2018-02-01 [Epub ahead of print].
[28] Hong TS, Wo JY, Mcdonnell EI, et al.A single arm phase 2 study of individualized proton-based stereotactic body radiation therapy (P-SBRT) of liver metastases[J]. Int J Radiat Oncol Biol Phys,2015,93(3):S112.
[29] Scorsetti M, Comito T, Tozzi A, et al.Final results of a phase Ⅱ trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer[J]. J Cancer Res Clin Oncol,2015,141(3):543-553.
[30] Yoshimoto M, Tada K, Nishimura S, et al.Favourable long-term results after surgical removal of lung metastases of breast cancer[J]. Breast Cancer Res Treat,2008, 110(3):485-491.
[31] Planchard D, Soria JC, Michiels S, et al.Uncertain benefit from surgery in patients with lung metastases from breast carcinoma[J]. Cancer,2004,100(1):28-35.
[32] Friedel G, Pastorino U, Ginsberg RJ, et al.Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the international registry of lung metastases[J]. Eur J Cardiothorac Surg,2002,22(3):335-344.
[33] Rusthoven KE, Kavanagh BD, Burri SH, et al.Multi-institutional phase Ⅰ/Ⅱ trial of stereotactic body radiation therapy for lung metastases[J]. J Clin Oncol,2009,27(10):1579-1584.
[34] Hof H, Hoess A, Oetzel D, et al.Stereotactic single-dose radiotherapy of lung metastases[J]. Strahlenther Onkol,2007,183(12):673-678.
[35] Patchell RA, Tibbs PA, Walsh JW, et al.A randomized trial of surgery in the treatment of single metastases to the brain[J]. N Engl J Med,1990,322(8):494-500.
[36] Patchell RA, Tibbs PA, Regine WF, et al.Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial[J]. JAMA,1998,280(17):1485-1489.
[37] Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery?[J]. Ann Neurol,1993,33(6):583-590.
[38] Noordijk EM, Vecht CJ, Haaxma-Reiche H, et al.The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age[J]. Int J Radiat Oncol Biol Phys,1994,29(4):711-717.
[39] Brown PD, Ballman KV, Cerhan JH, et al.Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial[J]. Lancet Oncol,2017,18(8):1049-1060.

Ⅳ期乳腺癌寡转移局部治疗的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价

[1]	张小丽　李赞　宋达疆　王业成　海涛.带蒂胸外侧动脉穿支皮瓣在保乳术后即刻乳房重建中的临床应用[J]. 组织工程与重建外科杂志, 2022, 18(5): 382-.
[2]	宋达疆　李赞　章一新.带蒂腹直肌皮瓣联合游离腹壁下动脉穿支皮瓣移植重建胸壁巨大缺损的手术策略[J]. 组织工程与重建外科杂志, 2022, 18(5): 386-.
[3]	姚成才　陈明　刘长春　黄传蔷　冼家仪　严国标　陈庞洲.硅凝胶乳房假体联合钛网补片在早期乳腺癌即刻乳房重建中的应用[J]. 组织工程与重建外科杂志, 2022, 18(3): 247-.
[4]	廖晓明　蒋奕　唐玮　杨华伟　姬逸男　韦莉颖.薄层血管化腹股沟淋巴结皮瓣移植联合反向淋巴显影在继发性上肢淋巴水肿手术中的应用[J]. 组织工程与重建外科杂志, 2022, 18(1): 8-.
[5]	宋景涌汤鹏钟晓捷刘侠孙洋亢玉王遥佳陈安玥陈怡安吉训通周艳虹蒋曼妃修骋穆籣.吻合口通畅性量化分析应用于乳腺癌腋窝淋巴结清扫术同期预防性淋巴管静脉吻合1例[J]. 组织工程与重建外科杂志, 2022, 18(1): 34-.
[6]	陈小松, 沈坤炜, 李宏为.早期可手术乳腺癌的诊治现状与展望[J]. 外科理论与实践, 2022, 27(05): 385-386.
[7]	吴佳毅, 陆裕杰, 何金光, 沈坤炜, 徐华.乳腺癌术后植入物乳房重建技术[J]. 外科理论与实践, 2022, 27(05): 387-391.
[8]	陈益定, 吴世杰.遗传性乳腺癌外科治疗[J]. 外科理论与实践, 2022, 27(05): 392-395.
[9]	谢妍妍, 吕青, 杜正贵.乳腺腔镜和机器人手术的现状及未来之路——华西医院经验分享[J]. 外科理论与实践, 2022, 27(05): 396-402.
[10]	周文斌, 唐新宇, 王水.局部微波消融技术在乳腺癌治疗中的应用[J]. 外科理论与实践, 2022, 27(05): 403-405.
[11]	曹璐, 郑思悦, 陈佳艺.早期乳腺癌区域淋巴结局部处理[J]. 外科理论与实践, 2022, 27(05): 406-410.
[12]	黄蔚, 李恒宇, 丁晓毅.晚期乳腺癌介入诊疗的价值及应用[J]. 外科理论与实践, 2022, 27(05): 411-415.
[13]	舒兰, 陈小松.ER⁺/HER2^-乳腺癌多基因阵列检测应用：ASCO指南解读与瑞金医院临床实践[J]. 外科理论与实践, 2022, 27(05): 416-420.
[14]	杨崔燕, 王豪雨, 陈小松, 沈坤炜.抑癌基因TP53突变状态与三阴性乳腺癌病人预后的研究[J]. 外科理论与实践, 2022, 27(05): 421-428.
[15]	潘睿忻综述, 陈小松, 沈坤炜审校.循环肿瘤DNA和循环肿瘤细胞检测乳腺癌微小残留病灶的研究[J]. 外科理论与实践, 2022, 27(05): 463-467.